Similar articles

• The immunogenetics of chronic graft versus host disease and its relevance for the graft versus leukemia effect.

  van Rood JJ, Goulmy E, van Leeuwen A. van Rood JJ, et al. Prog Clin Biol Res. 1987;244:433-8. Prog Clin Biol Res. 1987. PMID: 3310005 No abstract available.
• Incidence of anti-host cytotoxic and proliferative T cell responses after HLA-identical bone marrow transplantation (BMT).

  van Els C, Bakker A, Zwaan F, van Rood JJ, Goulmy E. van Els C, et al. Transplant Proc. 1989 Feb;21(1 Pt 3):2987-8. Transplant Proc. 1989. PMID: 2468249 No abstract available.
• Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease.

  Mutis T, Gillespie G, Schrama E, Falkenburg JH, Moss P, Goulmy E. Mutis T, et al. Nat Med. 1999 Jul;5(7):839-42. doi: 10.1038/10563. Nat Med. 1999. PMID: 10395333
• Graft-versus-leukaemia after bone marrow transplantation.

  Barret AJ. Barret AJ. Pediatr Med Chir. 1991 Jan-Feb;13(1):9-13. Pediatr Med Chir. 1991. PMID: 2052462 Review. No abstract available.
• Class-I-restricted human cytotoxic T lymphocytes directed against minor transplantation antigens and their possible role in organ transplantation.

  Goulmy E. Goulmy E. Prog Allergy. 1985;36:44-72. Prog Allergy. 1985. PMID: 3881782 Review. No abstract available.